Regencell Bioscience (RGC) has had the highest return this year by a mid-cap US stock, returning 12,325.1%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 2025 | 12,325.15% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 2025 | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 2025 | 1,634.05% |
Cidara Therapeutics (CDTX) | 2025 | 713.91% |
Terns Pharmaceuticals (TERN) | 2025 | 697.87% |
Celcuity LLC (CELC) | 2025 | 696.14% |
Sandisk (SNDK) | 2025 | 488.08% |
TMC the metals (TMC) | 2025 | 482.46% |
Olema Pharmaceuticals (OLMA) | 2025 | 458.28% |
Cogent Biosciences (COGT) | 2025 | 433.04% |
GRAIL, LLC (GRAL) | 2025 | 409.65% |
Planet Labs PBC (PL) | 2025 | 345.97% |
Aris Mining (ARMN) | 2025 | 342.54% |
Aura Minerals Inc Common Shares (AUGO) | 2025 | 312.38% |
ViaSat (VSAT) | 2025 | 307.16% |
Opendoor Technologies (OPEN) | 2025 | 303.69% |
Sibanye Gold Ltd ADR (SBSW) | 2025 | 289.74% |
Arrowhead Pharmaceuticals (ARWR) | 2025 | 270.06% |
CommScope (COMM) | 2025 | 269.58% |
Centrus Energy (LEU) | 2025 | 268.79% |
DRDGOLD Limited ADR (DRD) | 2025 | 263.36% |
Applied Digital (APLD) | 2025 | 254.9% |
Cipher Mining (CIFR) | 2025 | 251.96% |
Ondas (ONDS) | 2025 | 250% |
Praxis Precision Medicines (PRAX) | 2025 | 245.86% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
